BioRestorative Therapies enters agreements to exchange $9.25M notes and warrants for units in proposed offering

BioRestorative Therapies, Inc.

Exchanged aggregate $9,246,897 principal of convertible notes and warrants for units in proposed public offering.
Auctus Fund exchanged $8,826,952 principal and warrants for 13,766,343,425 shares; lock-up 4 months with 200% price trigger.
Three other holders exchanged $419,945 principal and warrants for 745,643,250 shares; same lock-up terms.
Exchanges conditioned on completion of public offering by January 31, 2022; otherwise agreements terminate.
May issue Series A preferred stock to cap beneficial ownership at 4.99% of common stock.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.